JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 34 No. 9 1447-1451
© 1993 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silverman, I. E.
Right arrow Articles by Alavi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silverman, I. E.
Right arrow Articles by Alavi, A.

SPECT in Patients With Cortical Visual Loss

Isaac E. Silverman, Steven L. Galetta, Lawrence G. Gray, Mark Moster, Scott W. Atlas, Alan H. Maurer and Abass Alavi

Departments of Neurology and Radiology, Divisions of Neuroradiology and Nuclear Medicine, University of Pennsylvania
Department of Neurology and Nuclear Medicine, Temple University, Philadelphia, Pennsylvania

Correspondence: For correspondence or reprints contact: Abass Alavi, MD, Div. Nuclear Medicine, Hospital of the University of Pennsylvania, 3400 Spruce St./G1, Philadelphia, PA 19104.

ABSTRACT

Single-photon emission computed tomography (SPECT) with 99mTc-hexamethyl propyleneamine oxine (HMPAO) was used to investigate changes in cerebral blood flow in seven patients with cortical visual impairment Traumatic brain injury (TBI) was the cause of cortical damage in two patients, cerebral ischemia in two patients and carbon monoxide (CO) poisoning, status epilepticus and Alzheimer's Disease (AD) each in three separate patients. The SPECT scans of the seven patients were compared to T2-weighted magnetic resonance image (MRI) scans of the brain to determine the correlation between functional and anatomical findings. In six of the seven patients, the qualitative interpretation of the SPECT studies supported the clinical findings (i.e., the visual field defect) by revealing altered regional cerebral blood flow (rCBF) in the appropriate regions of the visual pathway. MR scans in all of the patients, on the other hand, were either normal or disclosed smaller lesions than those detected by SPECT. We conclude that SPECT may reveal altered rCBF in patients with cortical visual impairment of various etiologies, even when MRI studies are normal or nondiagnostic.




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
Y.-J. Lee, T.-S. Chung, Y. Soo Yoon, M. Sik Lee, S.-H. Han, G. Je Seong, and K. Jin Ahn
The Role of Functional MR Imaging in Patients with Ischemia in the Visual Cortex
AJNR Am. J. Neuroradiol., June 1, 2001; 22(6): 1043 - 1049.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
R. Huo, S. K Burden, C. S Hoyt, and W. V Good
Chronic cortical visual impairment in children: aetiology, prognosis, and associated neurological deficits
Br. J. Ophthalmol., June 1, 1999; 83(6): 670 - 675.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1993 by the Society of Nuclear Medicine.